Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?When does the patent expire on ibranceAdefovir dipivoxil discount cardIs liver function monitoring necessary with lipitor
See the DrugPatentWatch profile for Zilretta
Zilretta® (buprenorphine) is a prescription medication that delivers a slow‑release, steady dose of the opioid partial agonist buprenorphine. It’s approved by the FDA for the treatment of moderate‑to‑severe chronic pain in adult patients who already require daily opioid therapy for pain management.
The exact dosing schedule is individualized by a prescriber; the above are general guidelines.
Zilretta is a long‑acting buprenorphine injection designed to provide consistent pain relief for patients already on daily opioids. It offers a safer profile compared to many full‑opioid agonists, but it still carries risks associated with opioids—especially respiratory depression and potential drug interactions. Because of its potency and the potential for serious side effects, it should only be used under close medical supervision.
Always discuss the risks, benefits, and your personal health history with your prescribing clinician before starting or changing any opioid therapy.
Other Questions About Zilretta :